Literature DB >> 12402980

Progesterone receptor mRNA variant containing novel exon insertions between exon 4 and exon 5 in human uterine endometrium.

Tomoya Yamanaka1, Shuji Hirata, Tomoko Shoda, Kazuhiko Hoshi.   

Abstract

The presence of human progesterone receptor (PR) mRNA variants has been demonstrated in uterine endometrium and breast tissues as well as in cancer cells of these tissues. While exon deletions by the alternative splicing in these variants have been reported, there are few reports available on the PR mRNA variants with exon insertion. In the present study, we attempted to detect a PR mRNA variant containing the exon insertions in normal uterine endometrium. Endometrial tissues were subjected to reverse transcription-polymerase chain reaction (RT-PCR) with PCR primers which were located in exons 3 and 8. Analysis of the RT-PCR products revealed the presence of a novel PR mRNA variant which contained a 232 bp inserted nucleotide sequence between exons 4 and 5. We termed this transcript the "i45 PR mRNA variant". Genomic analysis indicated that the inserted sequence was derived from two novel independent exons of 123 bp and 109 bp, termed "exon i45a" and "exon i45b", respectively, which are located between exons 4 and 5 of the human PR gene. The i45 PR mRNA variant was further detected in uterine endometrial cancer tissues as well as in the normal uterine endometrium. These results demonstrate the presence of a novel PR mRNA variant with exon insertions in the human tissue for the first time. The i45 PR variant protein, possibly transcribed from this i45 PR mRNA variant, may play physiological and/or pathological roles in the human uterine endometrium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402980     DOI: 10.1507/endocrj.49.473

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

Review 1.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

2.  The human progesterone receptor shows evidence of adaptive evolution associated with its ability to act as a transcription factor.

Authors:  Caoyi Chen; Juan C Opazo; Offer Erez; Monica Uddin; Joaquin Santolaya-Forgas; Morris Goodman; Lawrence I Grossman; Roberto Romero; Derek E Wildman
Journal:  Mol Phylogenet Evol       Date:  2008-02-01       Impact factor: 4.286

3.  Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative.

Authors:  David M W Cork; Thomas W J Lennard; Alison J Tyson-Capper
Journal:  Tumour Biol       Date:  2012-09-07

Review 4.  Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.

Authors:  Md Soriful Islam; Sadia Afrin; Sara Isabel Jones; James Segars
Journal:  Endocr Rev       Date:  2020-10-01       Impact factor: 19.871

Review 5.  Alternative splicing and the progesterone receptor in breast cancer.

Authors:  David M W Cork; Thomas W J Lennard; Alison J Tyson-Capper
Journal:  Breast Cancer Res       Date:  2008-05-30       Impact factor: 6.466

6.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.